Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Banned Hormone's Effects Last Three Generations

Grandsons of women who took DES more prone to genital defect

By Adam Marcus
HealthScoutNews Reporter


Related Encyclopedia
 border=
Acne
AIDS and HIV Infection
Alagille Syndrome
Amenorrhea
More...

Related Healthscout Videos
 border=
Weighted Belt for Autism?
Teaching Old Docs New Tricks
Lead in Soil.
Lead in Soil
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Dental Cavities
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Adderal XR
Cialis
Concerta
More...

Related News Articles
 border=
Children Aware of Racism
Focusing on School Could Prevent Teen Pregnancies
Low Vitamin D Tied to Estrogen Decline
Report: Young Athletes Need Dual Screening for Heart Defects
More...

THURSDAY, March 28 (HealthScoutNews) -- Boys whose grandmothers took a long-banned hormone treatment for troubled pregnancies appear to be at increased risk of a rare genital malformation.

A new study by Dutch scientists has found that the grandsons of women who took DES to stabilize pregnancy may be roughly 20 times more likely than other children to develop hypospadias, a rare birth defect in which the location of the urethra opening on the penis is askew.

The condition, which occurs in between two and six baby boys per 1,000, isn't life-threatening. But it often requires multiple surgeries to repair and can leave significant scars on a man's sexual confidence.

Text Continues Below



DES, or diethylstilbestrol, was a synthetic form of estrogen prescribed to 4 million pregnant women worldwide during the 1950s and 1960s on the shaky notion that it prevented miscarriages and preterm delivery.

The drug was banned in this country in 1971 (but was available in Europe for another seven years), after reports that it caused vaginal and cervical cancers, as well as fertility trouble, in the daughters of women who used it. Men whose mothers took DES were also at risk of urinary and genital defects, including various testicle problems.

Data in mice have shown that the drug's effects may extend into the third generation. But the new study, which appears this week in The Lancet, is the first to find such a legacy in humans.

Flora van Leeuwen, a cancer epidemiologist at the Netherlands Cancer Institute in Amsterdam, led the study. She and her colleagues compared the rate of hypospadias in 205 boys whose mothers were exposed to DES in the womb and 8,729 whose mothers weren't exposed to the drug.

Four of the 205 boys whose grandmothers had taken DES had hypospadias, compared with eight in the other group. In other words, van Leeuwen and her colleagues said, the odds of developing the defect were about 21 times higher than normal for the boys whose mothers had been exposed to DES as fetuses.

Page:  1 | 2 | Next >>

Copyright © 2002 ScoutNews, LLC. All rights reserved.
Last updated 3/28/2002

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Flora E van Leeuwen, Ph.D., professor of cancer epidemiology, The Netherlands Cancer Institute, Amsterdam; Sonia Hernandez-Diaz, M.D., Ph.D., assistant professor, Boston University School of Public Health; March 30, 2002 The Lancet


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy